Full-Time

Certified Athletic Trainer

Confirmed live in the last 24 hours

Cleveland Clinic

Cleveland Clinic

Non-profit academic medical center providing healthcare

No salary listed

Entry, Junior

Company Does Not Provide H1B Sponsorship

Massillon, OH, USA

The job is located at CC Union Hospital in Dover, Ohio.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree.
  • Completion of an athletic training program accredited by the Commission on Accreditation of Allied Health Education Programs.
  • Athletic Trainer certification (ATC) certified by the National Athletic Trainers Board of Certification (NATBOC).
  • State licensure as an Athletic Trainer (AT) if required by state law.
  • Basic Life Support (BLS) Healthcare Provider certification.
Responsibilities
  • Recognize, manage and rehabilitate injuries to professional, amateur and recreational athletes.
  • Provide techniques for prevention of injuries.
  • Prepare athletes for practice or competition.
  • Evaluate and manage injuries and determine whether a referral is necessary.
  • Maintain a medical file on each athlete and act as a liaison between the physician and the athlete.
  • Implement treatment and rehabilitation programs under the supervision of a physician.
  • Develop conditioning programs for injured and non-injured athletes.
  • For Athletic Trainers working in a clinical/ambulatory setting: perform a comprehensive health maintenance review, provide an oral report to the physician regarding patient history and chief complaint, scribe documentation of the visit into the medical record by remaining in the exam room with the physician as the patient is treated, review post-visit instructions with the patient, assist with gathering data under the supervision of the physician or nurse, and administer treatments under the direction of the physician.
Desired Qualifications
  • Participation in training programs related to the ATC field.

Cleveland Clinic is a non-profit academic medical center that provides high-quality clinical and hospital care, including routine check-ups, specialized treatments, and life-saving surgeries. It offers virtual visits and second opinions to improve accessibility and operates multiple locations in Ohio, Florida, Abu Dhabi, and Canada. The clinic generates revenue primarily through patient services and enhances the patient experience with resources like MyChart for health record management. Cleveland Clinic aims to deliver exceptional medical care, advance medical research, and educate future healthcare professionals.

Company Size

N/A

Company Stage

Grant

Total Funding

$74.7M

Headquarters

Cleveland, Ohio

Founded

1921

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in AI-powered healthcare solutions enhances data management capabilities.
  • Cleveland Clinic's involvement in neuromodulation therapies shows potential for growth in innovative treatments.
  • The NIH grant for virtual neighborhoods using EHR data enhances community health management.

What critics are saying

  • Competition from AI-powered healthcare data companies may challenge Cleveland Clinic's capabilities.
  • Rise of neuromodulation therapies may shift patient preferences from traditional treatments.
  • Development of virtual neighborhoods using EHR data could pose data privacy risks.

What makes Cleveland Clinic unique

  • Cleveland Clinic is a leader in medical research and education globally.
  • They offer comprehensive medical services, including virtual visits and second opinions.
  • Their global reach includes facilities in Ohio, Florida, Abu Dhabi, and Canada.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Mental Health Support

Company News

Finsmes
Dec 12th, 2024
1m Raises $10M in Series A Funding

1m raises $10M in Series A funding.

Hit Consultant
Oct 24th, 2024
Dyania Health Secures $10M for AI-Powered Chart Review

Dyania Health, an AI-powered healthcare data company, today announced the close of its $10 million Series A funding round led by Health..

PR Newswire
Aug 21st, 2024
Xii Medical Raises $45 Million In Series B Financing To Advance Best-In-Class Neuromodulation Therapy For Obstructive Sleep Apnea

Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activitiesUNION CITY, Calif., Aug. 21, 2024 /PRNewswire/ -- XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, today announced the closing of a $45 million Series B equity financing. The financing was led by Omega Funds and joined by new investor Intuitive Ventures. Existing investors also participated, including founding investor Cleveland Clinic, Ajax Health, Longview Ventures (an affiliate of Broadview Ventures), Aperture Venture Partners, JobsOhio Growth Capital Fund and an undisclosed strategic investor. Funds will be utilized to further product and clinical development. XII Medical has developed a state-of-the-art, patient-centric neuromodulation therapy designed to enhance quality of life for the millions of people suffering from obstructive sleep apnea.Obstructive sleep apnea (OSA) is a disorder in which the muscles in the throat temporarily relax, causing blockage of the airway during sleep

Finsmes
Aug 6th, 2024
Neurotherapia Raises $12.3M In Series B Funding

NeuroTherapia, a Cleveland, OH-based clinical-stage company focused on developing therapies for neurodegenerative diseases, raised $12.3M in Series B funding.The round was led by Cleveland Clinic, and included all previous investors, Brain Trust Accelerator Fund II, Dolby Family Ventures and the Alzheimer’s Drug Discovery Foundation (ADDF) as well as new investors, Foundation for a Better World and CRUINT. Led by President and CEO Tony Giordano, NeuroTherapia is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and other CNS conditions. NeuroTherapia is developing therapeutics that inhibit microglia cells, which are known to express proteins that drive inflammation in the CNS, without affecting the clearance of toxic beta amyloid.The company intends to use the funds for the continued clinical development of NTRX-07, an orally available cannabinoid receptor agonist, for the treatment of Alzheimer’s disease (AD). NeuroTherapia will continue to raise additional funds for its second close in six months, which will enable development of a recently discovered second generation molecule for a separate indication in which neuroinflammation plays a major role.FinSMEs06/08/2024

PR Newswire
Aug 1st, 2023
Enspire DBS Therapy Announces $17.6 Million Series B Financing to Advance the Development of Deep Brain Stimulation (DBS) plus Rehabilitation for Stroke Patients

/PRNewswire/ -- Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery,...